|
InSolution™ AMPK Inhibitor, Compound C
Dorsomorphin, BMP Inhibitor I, AMPK Inhibitor I
A cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo.
产品信息
Form Liquid
Formulation Supplied as a 10 mM (1 mg/250 µl) solution of AMPK Inhibitor, Compound C (Cat. No. 171260) in DMSO.
Primary Target AMPK
Primary Target Ki 109 nM
Molar mass 399.5
Protect from Light 是的
Hygrocopic 是的
Packaged under inert gas 是的
Cell permeable 是的
Reversible 是的
ATP Competitive 是的
Purity ≥95% by HPLC
Chemical formula C24H25N5O
CAS number 866405-64-3
商店和运输信息
Storage +2°C to +8°C
Ship Shipped with Blue Ice or with Dry Ice
Irritant |